Literature DB >> 32990569

Inflammatory Response after Different Ablation Strategies for Paroxysmal Atrial Fibrillation.

Guangli Yin1, Bofei Ma2, Bolun Zhou3, Jinglan Wu4, Ling You5, Ruiqin Xie6.   

Abstract

BACKGROUND: Catheter ablation for atrial fibrillation (AF) has been gaining popularity; however, the trend of inflammatory response markers in patients treated with different catheter ablation strategies over time and their predictability of AF recurrence remain unknown.
METHODS: A total of 210 patients with AF were enrolled and grouped according to surgical mode as follows: freeze group, RF group, and freeze3D group. The subjects were tested for related indexes before and after surgery. To determine AF recurrence during follow up, 24-h ambulatory electrocardiography was performed at two, three, six, and 12 months after surgery.
RESULTS: The inflammation indexes of the three groups peaked between one and three days after surgery but fell at different time points (P < .05). The recurrence rate of paroxysmal atrial fibrillation (PAF) was positively correlated with the increase in the percentage of white blood cells and neutrophils after surgery (P < .05).
CONCLUSIONS: The postoperative inflammation indices peaked and fell at different time points after different catheter ablation methods. In addition, the recurrence rate of AF in patients treated with freeze3D is lower.

Entities:  

Mesh:

Year:  2020        PMID: 32990569     DOI: 10.1532/hsf.3149

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  2 in total

1.  The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.

Authors:  Guodong Chang; Yingwei Chen; Zichang Liu; Yong Wang; Wenkun Ge; Yongan Kang; Shuling Guo
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

2.  The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery.

Authors:  Yu Luo; Jian Zhang; Tao Liu; Zongtao Yin; Yan Jin; Jinsong Han; Zhipeng Guo; Huishan Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-02-13       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.